Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Pharmacological Heart Rate Reduction on Visco-elastic Properties of the Arterial Wall (BRADYVASC)

NCT02584439 is registered in ClinicalTrials.gov with University Hospital, Rouen as lead sponsor.

NCT NCT02584439
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02584439 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Pharmacological Heart Rate Reduction on Visco-elastic Properties of the Arterial Wall (BRADYVASC)
Lead sponsor
University Hospital, Rouen
Phase
Phase 3
Overall status
Completed
Start date
December 3, 2015
Completion date
July 15, 2019
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aging, healthy, vascular stiffness